Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Association of Rare Variants in CYP2A13 with Lung Cancer Risk

FY 2019-20

Summary
"Cigarette smoking remains one of the most important public health problems worldwide. Lung cancer is one of the many serious pathologies associated with smoking; smoking causes nearly 90% of cases of lung cancer. Lung cancer risk in smokers is affected by genetics, because certain gene mutations can affect the processing of carcinogens in cigarette smoke. My work will focus on an enzyme in the lung called CYP2A13 which normally processes some ingredients in cigarette smoke, known as nitrosamines, into cancer-causing compounds. Some more common mutations in the CYP2A13 gene have been studied, and it has been found that they can lower the risk for lung cancer in smokers who carry those mutations. However, rare mutations which may have stronger effects on CYP2A13 have not been studied. In this study, I will find rare CYP2A13 mutations in a group of smokers by collecting their genetic data, and analyze the mutations to discover if they negatively affect CYP2A13's ability to process nitrosamines. We will then do a study to see if there is a relationship between the mutations that affect CYP2A13 and the risk of lung cancer. In the end, this work will allow us to better understand how CYP2A13 and lung cancer are connected, and more specifically understand the role of rare mutations in CYP2A13 in lung cancer risk."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428916
Name
Langlois Alec
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Association of Rare Variants in CYP2A13 with Lung Cancer Risk
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Case-Control; Cyp2a13; Cytochrome P450 2a; Functional Analysis; Lung Cancer; Pharmacogenetics; Rare Variants; Smoking
Abstract
"Cigarette smoking remains one of the most important public health problems worldwide. Lung cancer is one of the many serious pathologies associated with smoking; smoking causes nearly 90% of cases of lung cancer. Lung cancer risk in smokers is affected by genetics, because certain gene mutations can affect the processing of carcinogens in cigarette smoke. My work will focus on an enzyme in the lung called CYP2A13 which normally processes some ingredients in cigarette smoke, known as nitrosamines, into cancer-causing compounds. Some more common mutations in the CYP2A13 gene have been studied, and it has been found that they can lower the risk for lung cancer in smokers who carry those mutations. However, rare mutations which may have stronger effects on CYP2A13 have not been studied. In this study, I will find rare CYP2A13 mutations in a group of smokers by collecting their genetic data, and analyze the mutations to discover if they negatively affect CYP2A13's ability to process nitrosamines. We will then do a study to see if there is a relationship between the mutations that affect CYP2A13 and the risk of lung cancer. In the end, this work will allow us to better understand how CYP2A13 and lung cancer are connected, and more specifically understand the role of rare mutations in CYP2A13 in lung cancer risk."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Langlois, Alec
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~